The Impact of Hypertension in Hemodialysis Patients
Journal:
Current Hypertension Reviews
Volume:
4
Page:
100-106
Author(s):
Riccardo Maria Fagugli, Chiara Taglioni, Davide Rossi and Daniela Ricciardi
Potential Benefits of Glitazones for Cancer and Vascular Disease
Journal:
Current Drug Therapy
Volume:
3
Page:
111-125
Author(s):
Jose M. Perez-Ortiz, Silvia Llorens, Juan Llopis, Pedro A. Tranque and Eduardo Nava
The Pharmacological Management of Delirium in Critical Illness
Journal:
Current Drug Therapy
Volume:
3
Page:
148-157
Author(s):
Alessandro Morandi, Max L. Gunther, E. Wesley Ely and Pratik Pandharipande
The Molecular Basis of Class Side Effects Due to Treatment with Inhibitors of the VEGF/VEGFR Pathway
Journal:
Current Clinical Pharmacology
Volume:
3
Page:
132-143
Author(s):
Jeanine M. Roodhart, Marlies H. Langenberg, Els Witteveen and Emile E. Voest
Central Nervous System Abnormalities in Fibromyalgia and Chronic Fatigue Syndrome: New Concepts in Treatment
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
1274-1294
Author(s):
Ali Gur and Pelin Oktayoglu
Adenosine A2A Receptor Antagonists and Parkinsons Disease: State of the Art and Future Directions
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
1475-1489
Author(s):
N. Simola, M. Morelli and A. Pinna
Modulation of Ischemic Brain Injury and Neuroinflammation by Adenosine A2A Receptors
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
1490-1499
Author(s):
Jiang-Fan Chen and Felicita Pedata
Potential Therapeutic Interest of Adenosine A2A Receptors in Psychiatric Disorders
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
1512-1524
Author(s):
Rodrigo A. Cunha, Sergi Ferre, Jean-Marie Vaugeois and Jiang-Fan Chen
A2A Adenosine Receptor and its Modulators: Overview on a Druggable GPCR and on Structure-Activity Relationship Analysis and Binding Requirements of Agonists and Antagonists
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
1525-1552
Author(s):
G. Cristalli, C. Lambertucci, G. Marucci, R. Volpini and D. Dal Ben
Side Effects of Clozapine and Some Other Psychoactive Drugs
Journal:
Current Drug Safety
Volume:
3
Page:
115-122
Author(s):
Robert J. Flanagan